IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives

Biochemistry, Genetics and Molecular Biology

• IDH1 100%
• Epigenetics 66%
• Lysozyme 50%
• Electric Potential 33%
• Metabolic Pathway 16%
• Nested Gene 16%
• Mutation 16%
• Gene Mutation 16%
• Histone 16%
• Small Molecule 16%
• Point Mutation 16%
• Cell Survival 16%
• Cellular Differentiation 16%
• Demethylase 16%
• Next Generation Sequencing 16%
• DNA 16%
• Mutant 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Bile Duct Carcinoma 66%
• Enzyme 50%
• Neoplasm 16%
• Prognosis 16%
• Malignant Neoplasm 16%
• DNA 16%
• Primary Tumor 16%
• Drug 16%
• 2 Hydroxyglutaric Acid 16%
• Symptom 16%
• Survival 16%